Evaluation of the Safety and Immunogenicity of the RTS,S/AS01_EMalaria Candidate Vaccine When Integrated in the Expanded Program of Immunization

Abstract

RTS,S/AS01(E) integrated in the EPI showed a favorable safety and immunogenicity evaluation. Trial registration. ClinicalTrials.gov identifier: NCT00436007 . GlaxoSmithKline study ID number: 106369 (Malaria-050).